PURR
NASDAQ · Biotechnology

Hyperliquid Strategies

$12.85
-1.24 (-8.80%)
As of Sep 27, 10:25 PM ET ·
Financial Highlights (FY 2026)
Revenue
30.91M
Net Income
—
Gross Margin
—
Profit Margin
—
Rev Growth
—
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — 34.5% 34.5% 34.5%
Operating Margin — 14.1% 13.9% 14.1%
Profit Margin — 8.9% 9.4% 9.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 30.91M 243.91M 233.99M 197.33M
Gross Profit — 84.08M 80.65M 68.02M
Operating Income — 34.39M 32.57M 27.86M
Net Income — 21.63M 22.04M 17.71M
Gross Margin — 34.5% 34.5% 34.5%
Operating Margin — 14.1% 13.9% 14.1%
Profit Margin — 8.9% 9.4% 9.0%
Rev Growth — -3.3% +11.1% +4.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 193.52M 180.27M 190.43M
Total Equity — 332.54M 294.59M 328.44M
D/E Ratio — 0.58 0.61 0.58
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA — 48.94M 46.22M 40.39M
Free Cash Flow — 24.46M 20.15M 20.27M